ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

GMDA Gamida Cell Ltd

0.0327
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Gamida Cell Ltd GMDA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.0327 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0327 0.0327
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/4/202406:30GLOBEXORTX Welcomes New Member to the Board of Directors
01/4/202407:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
27/3/202405:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
14/2/202413:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202405:31EDGAR2Form 8-K - Current report
08/1/202406:00EDGAR2Form 8-K - Current report
18/12/202305:28EDGAR2Form 8-K - Current report
14/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202316:24EDGAR2Form S-3/A - Registration statement under Securities Act of..
24/11/202315:15EDGAR2Form 8-K - Current report
20/11/202316:27EDGAR2Form SC 13D/A - General statement of acquisition of..
15/11/202316:24EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202306:00EDGAR2Form 8-K - Current report
14/11/202306:00GLOBEGamida Cell Reports Third Quarter 2023 Financial Results and..
08/11/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202315:01EDGAR2Form 8-K - Current report
11/10/202306:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/10/202315:01EDGAR2Form SC 13D/A - General statement of acquisition of..
29/9/202307:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/9/202315:43EDGAR2Form 8-K - Current report
13/9/202315:01EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202315:08EDGAR2Form PRE 14A - Other preliminary proxy statements
21/8/202316:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/8/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202315:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:30EDGAR2Form 8-K - Current report
11/7/202307:00BWData Published in Transplantation and Cellular Therapy..
10/7/202313:00PRNUSSTAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE..
14/6/202315:30BWGamida Cell To Host Investor Day
31/5/202315:30BWGamida Cell to Present Corporate Highlights at the Jefferies..
31/5/202306:00BWData To Be Presented on Gamida Cell Natural Killer (NK) Cell..
22/5/202307:00BWGamida Cell Appoints Terry Coelho as CFO
15/5/202315:05BWGamida Cell Reports First Quarter 2023 Financial Results and..
11/5/202316:20BWGamida Cell Announces the Date of Its First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock